MarketsandMarkets

Advanced Genetic Sequencing Virtual Conference [Time zone- Eastern Standard Time (EST)]

23rd -24th September 2021

Nanopore sequencing and its application to pandemic epidemiological survey of SARS CoV-19 and strains surveillance. Now, with COVID therapeutic manufacturing taking priority, there is a big desire to accelerate other clinical pipeline because of ample opportunity for new medicine.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September 2021 will hold discussions on trending technologies and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

MarketsandMarkets is proud to announce the Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23-24 September presents to you a virtual platform to keep your scientific exchange live. It will hold discussions on trending technologies of sequencing and its applications, challenges of implying these technologies into clinical specimen, practice of sequencing in healthcare domain specifically to cancer cells, overview of the data used in these technologies and its applications. This event will witness an overwhelming participation of leading healthcare and industry decision makers.

WHAT TO EXPECT

  • Short Read Sequencing & Long Read Sequencing – Single cell Analysis 
  • Human disease – Virus interacts with DNA and how sequencing helps in it. 
  • Spatial sequencing and its applications 
  • What’s new in Nano pore sequencing technology. Applications of Nano pore sequencing in healthcare 
  • Nano pore sequencing to pandemic epidemiology survey of Covid-19 and strain surveillance 
  • A multipanel IS and its uses in IHC

  • Learn about the recent trends and advancements occurring in Sequencing market.
  • Engage in meaningful discussion with the most prominent industry experts and decision makers from pharmaceutical manufactures, therapeutic companies and Healthcare who will address most critical challenges in different sequencing process.
  • Opportunity to network and exchange scientific knowledge with expert speakers from leading manufacturers, global regulators, and solution providers

 

Professionals in Healthcare, Therapeutics, Universities/ Pharmaceuticals:

  • C-Level
  • Vice Presidents
  • Presidents
  • Senior Directors
  • Directors
  • Global Heads
  • Heads
  • Managers

Working in departments of Bioinformatics, Genomics, Molecular Biology, Oncology, Biotechnology and Biochemistry

CONFERENCE AGENDA

Registration

 08:20 - 08:50

Welcome note from MarketsandMarkets

 08:50 - 08:55

Opening remarks from the Chairman

 08:55 - 09:00

OVERVIEW OF SEQUENCING AND ITS RECENT INNOVATIONS

Keynote Presentation: Deep Functional Annotation of Single Cell RNA-seq Datasets

Jonathan Preall

Jonathan Preall, Research Assistant Professor, Cold Spring Harbor Laboratory

 09:00 - 09:30

Introducing Biomek NGeniuS

Bhagya Wijayawardena

Bhagya Wijayawardena, Global Commercial Product Manager, Beckman Coulter

 09:30 - 10:00

DEMOCRATIZATION OF SEQUENCING AND ITS APPLICATIONS

Recent advancements in Mendelian genomics

Shrikant Mane

Shrikant Mane, Executive Director, Yale Center for Genome Analysis (YCGA)

 10:00 - 10:30

Combining sequence and structure information from DNA (genomics), RNA (coding and noncoding), and proteins, to better understand genome organization and function

Miten Jain

Miten Jain, Assistant Research Scientist, University of California Santa Cruz

 10:30 - 11:00

Clinical implementation of SMRT sequencing for Precision Medicine in Immune diseases

Paul ‏Keown

Paul ‏Keown, Professor of Medicine, University of British Columbia

 11:00 - 11:30

Single cell sequencing: a powerful approach to profile tumor microenvironment

Ning Wang

Ning Wang, Bioinformatics Lead, Arcus Biosciences

 11:30 - 12:00

Closing remarks from the chairperson

Matt Davis

Matt Davis, Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

12:00 - 12:05

One-to-One Networking Meetings | Networking break- virtual networking lounge End of Day 1

 12:05 - 12:05

Registration

 08:20 - 08:50

Welcome note from MarketsandMarkets

 08:50 - 08:55

Opening remarks from the Chairman

 08:55 - 09:00

SEQUENCING TECHNOLOGY IN CLINICAL APPLICATIONS

Keynote Presentation- Neoantigen Targeted Cancer Immunotherapy in the Clinic

Matt Davis

Matt Davis, Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

09:00 - 09:30

An Overview of Spatial Transcriptomics: Techniques and Applications

Catia Moutinho

Catia Moutinho, Group Leader Single Cell Technology Development, GWCCG, Australia

 09:30 - 10:00

Model-based analysis of alternative polyadenylation using 3’ end reads

Wei Vivian

Wei Vivian, Assistant Professor, Rutgers School of Public Health

 10:00 - 10:30

Species-level 16S Microbiome Via Simultaneous, Weighted Analysis of ALL Hypervariable Domains

Seth Crosby

Seth Crosby, Director, Research Collaborations, Washington University School of Medicine

 10:30 - 11:00

Dual methylation and mutation analysis from a single input of plasma cfDNA without sample splitting

Grace Zhao

Grace Zhao, Co- Founder, Avida Biomed

 11:00 - 11:30

Closing Remarks from the Chairperson

11:30 - 11:35

 End of Conference and One on One Networking on the Event Portal

 11:35 - 11:35

CONFERENCE SPEAKERS

ADVISORS

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

SPEAKERS

Dr. Catia Moutinho

Dr. Catia Moutinho

Group Leader Single Cell Technology Development, GWCCG, Australia

Wei Vivian

Wei Vivian

Assistant Professor, Rutgers School of Public Health

Ning Wang

Ning Wang

Bioinformatics Lead, Arcus Biosciences

Grace Zhao

Grace Zhao

Co- Founder, Avida Biomed

Bhagya Wijayawardena

Bhagya Wijayawardena

Global Commercial Product Manager, Beckman Coulter

Shrikant Mane

Shrikant Mane

Executive Director, Yale Center for Genome Analysis (YCGA)

Seth Crosby

Seth Crosby

Director, Research Collaborations, Washington University School of Medicine

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

Paul ‏Keown

Paul ‏Keown

Professor of Medicine, University of British Columbia

Karen Sherwood

Karen Sherwood

Director of Scientific Programs, Lead scientist, Genome Canada Transplant Consortium

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

Muthuirulan Pushpanathan

Muthuirulan Pushpanathan

Research Scientist, Harvard University

Jonathan Preall

Jonathan Preall

Research Assistant Professor, Cold Spring Harbor Laboratory

SPONSORS

Beckman Coulter

PARTNERS

PharmaTutor
Pharma Journalist
This Week in Digital Health

24/7 Customer Support

Asia Office

Phone : +91 20 48598285
[email protected]

USA Office

Phone : +1-888600-6441
[email protected]